Skip to main content
. 2018 Oct 29;8(2):e1532763. doi: 10.1080/2162402X.2018.1532763

Figure 6.

Figure 6.

Effects of ONCOS-102 and pembrolizumab on number of hCD45+ leukocytes. A. Number of hCD45+ leukocytes per gram of tumor on left and right flank. B. Percentage of hCD3+ leukocytes among hCD45+ leukocytes in tumors on left and right flank. The populations were gated with forward and side scattering (FSC-A/SSC-A dot plot) in leukocytic regions (at least 104 cells/events were analyzed by flow cytometry, 6–8 tumors/experimental group have been analysed in one experimental replicate). Flow cytometry analysis was performed on FlowJo v10 software. Data represent mean ± SEM. n = 2–6, P* < 0.05, P** < 0.01 vs vehicle.